In situ photoimmunotherapy for melanoma: preliminary clinical results

Mark F. Naylor; Robert E. Nordquist; T. Kent Teauge; Lisa A. Perry; Wei R. Chen

doi:10.1117/12.644882

24 February 2006 In situ photoimmunotherapy for melanoma: preliminary clinical results

Mark F. Naylor, Robert E. Nordquist, T. Kent Teauge, Lisa A. Perry, Wei R. Chen

Proceedings Volume 6087, Biophotonics and Immune Responses; 608709 (2006) https://doi.org/10.1117/12.644882
Event: SPIE BiOS, 2006, San Jose, California, United States

Abstract

Although melanoma accounts for only 4% of skin cancer cases, it causes 79% of all skin cancer deaths. Patients with metastatic melanoma have a poor prognosis, and long term survival is only about 5% [1, 2]. Conventional therapies such as surgery and radiation therapy usually do not cure stage III or stage IV melanoma, while traditional chemotherapy is primarily palliative. Over the last decade we have been developing new methods for treating solid tumors like melanoma, first in animal models and now in humans. We present here preliminary results from a new technique that utilizes a combination of laser stimulation and drug therapy to stimulate brisk immunological responses in cases of advanced melanoma with cutaneous metastases. A high-power, near-infrared diode laser (805 nm) is used to kill tumors in situ and a topical toll-like receptor agonist (imiquimod cream, 5%) is used to intensify the resulting immunological response. This is essentially an in situ, tumor vaccine approach to treating solid tumors.

Citation Download Citation

Mark F. Naylor, Robert E. Nordquist, T. Kent Teauge, Lisa A. Perry, and Wei R. Chen "In situ photoimmunotherapy for melanoma: preliminary clinical results", Proc. SPIE 6087, Biophotonics and Immune Responses, 608709 (24 February 2006); https://doi.org/10.1117/12.644882

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available